One-electron reduction of mitomycin c by rat liver: Role of cytochrome P-450 and NADPH-cytochrome P-450 reductase

References

• Ahr H. J., King L. J., Nastainczyk W., Ullrich V. The mechanism of reductive dehalogenation of halothane by liver cytochrome P-450. Biochemical Pharmacology 1982; 31: 383–390
   PubMed Web of Science ®Google Scholar
• Anders M. W., Englisch J. C. Reduction of halogenated compounds by cytochrome P450. Microsomes and Drug Oxidations, A. R. Boobis. Taylor & Francis, London 1985; 274
   Google Scholar
• Bast A. Is formation of reactive oxygen by cytochrome P-450 perilous and predictable?. Trends in Pharmacological Sciences 1986; 7: 266–270
   Web of Science ®Google Scholar
• Burke D., Mayer R. Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450 binding of phenoxatone and a homologous series of its n-alkyl ethers (alkoxyresorufins). Chemico-Biological Interactions 1983; 45: 243–258
   PubMed Web of Science ®Google Scholar
• Capdevilla J., Estabrook R. W., Prough R. A. The existence of a benzo(a)pyrene-3,6-quinone reductase in rat liver microsomal fractions. Biochemical and Biophysical Research Communications 1978; 83: 1291–1298
   PubMed Web of Science ®Google Scholar
• Englander S., Calhown D., Englander J. Biochemistry without oxygen. Analytical Biochemistry 1987; 161: 300–306
   PubMed Web of Science ®Google Scholar
• Fujita S., Peisach J. Liver microsomal cytochromes P-450 and azoreductase activity,. Journal of Biological Chemistry 1978; 253: 4512–4513
   PubMed Web of Science ®Google Scholar
• Glisson B. S., Ross W. E. DNA Topoisomerase II: a primer on the enzyme and its unique role as a multichange target in cancer chemotherapy. Pharmacology and Therapeutics 1987; 32: 89–106
   PubMed Web of Science ®Google Scholar
• de Groot H., Noll T. The crucial role of low steady state oxygen partial pressures in haloalkane free-radical-mediated lipid peroxidation. Biochemical Pharmacology 1986; 35: 15–19
   PubMed Web of Science ®Google Scholar
• Harada N., Omura T. Journal of Biochemistry (Tokyo) 1980; 87: 1539
   PubMed Web of Science ®Google Scholar
• Hildebrandt A. G., Roots I., Tjoe M., Heinemeyer G. Hydrogen peroxide in hepatic microsomes,. Methods in Enzymology, 52, S. Fleischer, L. Packer. Academic Press, New York 1978; 342
   Google Scholar
• Kappus H. Overview of enzyme systems involved in bioreduction of drugs and redox-cycling. Biochemical Pharmacology 1986; 35: 1–6
   PubMed Web of Science ®Google Scholar
• Kennedy K. A., Sliger S. G., Polonksi L., Sartorelli A. C. Metabolic activation of mitomycin c by liver microsomes and nuclei. Biochemical Pharmacology 1982; 31: 2011–2016
   PubMed Web of Science ®Google Scholar
• Keyes S., Heimbrook D., Fraccaso P., Rockwell S., Sligar S. G., Sartorelli A. Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin c. Advances in Enzymatic Regulation 1985; 23: 291
   PubMed Web of Science ®Google Scholar
• Levine W. G., Raza H. Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin c. Mechanism of azoreduction of dimethylaminoazobenzene by rat liver NADPH-cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and stimulation by FAD and FMN. Drug Metabolism and Disposition 1988; 16: 441–448
   PubMed Web of Science ®Google Scholar
• Mallet A. K., King L. J., Walker R. Solubilisation, purification and reconstitution of hepatic microsomal azoreductase activity. Biochemical Pharmacology 1985; 34: 337–342
   PubMed Web of Science ®Google Scholar
• Mayer R. T., Jermyn J. W., Burke M. D., Prough R. A. Methoxyresorufin as a substrate for the fluorometric assay of insect microsomal O-dealkylases. Pesticide Biochemistry and Physiology 1977; 7: 349–357
   Web of Science ®Google Scholar
• Moore H. Bioactivation as a model for drug design on bioreductive alkylation. Science 1977; 197: 527–532
   PubMed Web of Science ®Google Scholar
• Nash T. Colorimetric estimation of formaldehyde by means of Hantzsch reaction. Biochemical Journal 1953; 55: 416–421
   PubMed Web of Science ®Google Scholar
• Nastainczyk W., Ahr H. J., Ullrich V. The reductive metabolism of halogenated alkanes by liver microsomal cytochrome P-450. Biochemical Pharmacology 1982; 31: 391–396
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. Evidence for its hemoprotein nature. Journal of Biological Chemistry (Tokyo) 1964; 237: 2370–2378
   Google Scholar
• Phillips A., Langdon R. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation characterisation and kinetic studies. Journal of Biological Chemistry 1962; 237: 2652
   PubMed Web of Science ®Google Scholar
• Porumb H., Peterscu I. Interaction with mitochondria of the anthracyline cytostatics adriamycin and daunomycin. Progress in Biophysics and Molecular Biology 1986; 48: 103–125
   PubMed Web of Science ®Google Scholar
• Powis G. Metabolism and reactions of quinoid anticancer agents. Pharmacology and Therapeutics 1987; 35: 57–162
   PubMed Web of Science ®Google Scholar
• Pullman B. A few considerations on quinones as antitumor agents. International Journal of Quantum Chemistry 1986; 13: 95–105
   Google Scholar
• RumYanTseva G. V., Sushkov D. G., Weiner L. M. Microsomal oxidation of 2-dimethylamino-3-chloro-1,4-naphthoquinone. The possibility of substrate activation by cytochrome P-450. Xenobiotica 1986; 16: 167–175
   PubMed Web of Science ®Google Scholar
• Schenkman J. B., Remmer H., Estabrook R. W. Spectral studies of drug interaction with hepatic microsomal cytochrome P-450. Molecular Pharmacology 1967; 3: 113–123
   PubMed Web of Science ®Google Scholar
• Schenkman J. B., Cinti D. L., Orrenius S., Moldéus P., Kaschnitz R. The nature of reverse type I (modified type II) spectral change in liver microsomes. Biochemistry 1972; 11: 4243–4251
   PubMed Web of Science ®Google Scholar
• Shen A. L., Fahl W. E., Wrighton S. A., Jefcoate C. R. Inhibition of benzo(a)pyrene and benzo(a)pyrene 7,8-dihydrodiol metabolism by benzo(a)pyrene quinones. Cancer Research 1979; 39: 4123
   PubMed Web of Science ®Google Scholar
• Sies H. Biochemie des oxidativen stress. Angewandie Chemie International Edition in English 1986; 98: 1061–1075
   Google Scholar
• van de Vries Straat R., de J., Vermeulen N. P. E. Role of hepatic microsomal and purified cytochrome P-450 in one-electron reduction of two quinone imines and concomitant reduction of molecular oxygen. Biochemical Pharmacology 1987; 36: 613–619
   PubMed Web of Science ®Google Scholar
• van de Straat R., de Vries J., de Boer H. J. R., Vromans R. M., Vermeulen N. P. E. Relationship between paracetamol binding to and its oxidation by two cytochrome P-450 isozymes. A proton nuclear magnetic resonance and spectrophotometric study,. Xenobiotica 1987b; 17: 1–9
   PubMed Web of Science ®Google Scholar
• Strobel H. W., Dignam D. J. Purification and properties of NADPH-cytochrome P-450 reductase,. Methods in Enzymology, 52, S. Fleischer, L. Packer. Academic Press, New York 1978; 89
   Google Scholar
• Testa B., Jenner P. Inhibitors of cytochrome P-450 and their mechanism of action. Drug Metabolism Reviews 1981; 12: 1–117
   PubMed Web of Science ®Google Scholar
• Tomasz M., Lipman R., Chowdary D., Pawlak J., Verdine G., Nakanishi K. Isolation and structure of a covalent cross-link adduct between mitomycin c and DNA. Science 1987; 235: 1024–1208
   Web of Science ®Google Scholar
• Weiner L. M., Gritzan N. P., Bazhin N. M., Lyakhovich V. V. Microsomal and photochemical oxidation and reduction of 1-piperidinoanthraquinone. Biochimica et Biophysica Acta 1982; 714: 234–242
   PubMed Web of Science ®Google Scholar